☰

Michael Aman - Publications

Affiliations: 
Psychology Ohio State University, Columbus, Columbus, OH 
Area:
Physiological Psychology
Tree Info Grants Similar researchers PubMed Report error

167/373 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Mansour R, Ward AR, Lane DM, Loveland KA, Aman MG, Jerger S, Schachar RJ, Pearson DA. ADHD severity as a predictor of cognitive task performance in children with Autism Spectrum Disorder (ASD). Research in Developmental Disabilities. 111: 103882. PMID 33548744 DOI: 10.1016/j.ridd.2021.103882  0.364
2021 Lee RR, Ward AR, Lane DM, Aman MG, Loveland KA, Mansour R, Pearson DA. Executive Function in Autism: Association with ADHD and ASD Symptoms. Journal of Autism and Developmental Disorders. PMID 33515417 DOI: 10.1007/s10803-020-04852-2  0.344
2021 Cariveau T, McCracken CE, Bradshaw J, Postorino V, Shillingsburg MA, McDougle CJ, Aman MG, McCracken JT, Tierney E, Johnson C, Lecavalier L, Smith T, Swiezy NB, King BH, Hollander E, et al. Gender Differences in Treatment-Seeking Youth with Autism Spectrum Disorder Journal of Child and Family Studies. 30: 784-792. DOI: 10.1007/S10826-021-01905-7  0.31
2020 Johnstone JM, Leung BMY, Srikanth P, Hatsu I, Perez L, Gracious B, Tost G, Aman MG, Gadow KD, Findling RL, Bukstein O, Arnold LE. Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation. Journal of Child and Adolescent Psychopharmacology. PMID 32101469 DOI: 10.1089/Cap.2019.0179  0.331
2019 Grondhuis SN, Farmer CA, Arnold LE, Gadow KD, Findling RL, Molina BSG, Kolko DJ, Buchan-Page KA, Rice RR, Butter EM, Aman MG. Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study. Journal of Child and Adolescent Psychopharmacology. PMID 31730370 DOI: 10.1089/Cap.2019.0109  0.795
2019 Bangerter A, Ness S, Lewin D, Aman MG, Esbensen AJ, Goodwin MS, Dawson G, Hendren R, Leventhal B, Shic F, Opler M, Ho KF, Pandina G. Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 30888551 DOI: 10.1007/S10803-019-03965-7  0.684
2019 Scahill L, Lecavalier L, Schultz RT, Evans AN, Maddox B, Pritchett J, Herrington J, Gillespie S, Miller J, Amoss RT, Aman MG, Bearss K, Gadow K, Edwards MC. Development of the Parent-Rated Anxiety Scale for Youth with Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797036 DOI: 10.1016/J.Jaac.2018.10.016  0.341
2019 Norris M, Aman MG, Mazurek MO, Scherr JF, Butter EM. Psychometric characteristics of the aberrant behavior checklist in a well-defined sample of youth with autism Spectrum disorder Research in Autism Spectrum Disorders. 62: 1-9. DOI: 10.1016/J.Rasd.2019.02.001  0.417
2019 Postorino V, Gillespie S, Lecavalier L, Smith T, Johnson C, Swiezy N, Aman MG, McDougle CJ, Bearss K, Andridge RR, Vitiello B, Scahill L. Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems Journal of Child and Family Studies. 28: 2069-2077. DOI: 10.1007/S10826-019-01423-7  0.364
2018 Joseph HM, Farmer C, Kipp H, Kolko D, Aman M, McGinley J, Arnold LE, Gadow KD, Findling RL, Molina BSG. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression. Journal of Child and Adolescent Psychopharmacology. PMID 30592635 DOI: 10.1089/Cap.2018.0119  0.466
2018 Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Comprehensive Psychiatry. 88: 57-64. PMID 30504071 DOI: 10.1016/J.Comppsych.2018.10.012  0.381
2018 Handen BL, Veenstra-VanderWeele J, Anagnostou E, Aman MG. Dr. Handen et al. Reply. Journal of the American Academy of Child and Adolescent Psychiatry. 57: 793-795. PMID 30274655 DOI: 10.1016/J.Jaac.2018.08.005  0.333
2018 Barrie ES, Pinsonneault JK, Sadee W, Hollway JA, Handen BL, Smith T, Arnold LE, Butter E, Hansen-Kiss E, Herman GE, Aman MG. Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD. Journal of Developmental and Physical Disabilities. 30: 355-371. PMID 30197492 DOI: 10.1007/S10882-018-9590-4  0.688
2018 Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism. Journal of Child and Adolescent Psychopharmacology. PMID 29694241 DOI: 10.1089/Cap.2017.0134  0.745
2018 Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, Macklin E, Arnold LE, Wong T, Newsom C, Hastie Adams R, Marler S, Peleg N, Anagnostou EA. Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use. Journal of Child and Adolescent Psychopharmacology. PMID 29620914 DOI: 10.1089/Cap.2017.0072  0.676
2018 Grondhuis SN, Lecavalier L, Arnold LE, Handen BL, Scahill L, McDougle CJ, Aman MG. Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder Research in Autism Spectrum Disorders. 49: 47-55. DOI: 10.1016/J.Rasd.2018.02.001  0.811
2017 Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 29112459 DOI: 10.1089/Cap.2017.0085  0.728
2017 Lecavalier L, Pan X, Smith T, Handen BL, Arnold LE, Silverman L, Tumuluru RV, Hollway J, Aman MG. Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 29022125 DOI: 10.1007/S10803-017-3345-4  0.727
2017 Handen BL, Anagnostou E, Aman MG, Sanders KB, Chan J, Hollway JA, Brian J, Arnold LE, Capano L, Williams C, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, et al. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 849-856.e6. PMID 28942807 DOI: 10.1016/J.Jaac.2017.07.790  0.708
2017 Tumuluru RV, Corbett-Dick P, Aman MG, Smith T, Arnold LE, Pan X, Buchan-Page KA, Brown NV, Ryan MM, Hyman SL, Hellings J, Williams C, Hollway JA, Lecavalier L, Rice RR, et al. Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism. Journal of Child and Adolescent Psychopharmacology. PMID 28509573 DOI: 10.1089/Cap.2016.0187  0.741
2017 Bangerter A, Ness S, Aman MG, Esbensen AJ, Goodwin MS, Dawson G, Hendren R, Leventhal B, Khan A, Opler M, Harris A, Pandina G. Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 28498053 DOI: 10.1089/cap.2017.0018  0.669
2017 Criado KK, Sharp WG, McCracken CE, De Vinck-Baroody O, Dong L, Aman MG, McDougle CJ, McCracken JT, Eugene Arnold L, Weitzman C, Leventhal JM, Vitiello B, Scahill L. Overweight and obese status in children with autism spectrum disorder and disruptive behavior. Autism : the International Journal of Research and Practice. 1362361316683888. PMID 28325061 DOI: 10.1177/1362361316683888  0.365
2017 Findling RL, Townsend L, Brown NV, Arnold LE, Gadow KD, Kolko DJ, McNamara NK, Gary DS, Kaplin DB, Farmer CA, Kipp H, Williams C, Butter EM, Bukstein OG, Rice R, ... Aman MG, et al. The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders. Journal of Child and Adolescent Psychopharmacology. 27: 52-65. PMID 28212067 DOI: 10.1089/Cap.2016.0081  0.321
2017 Bangerter A, Ness S, Lewin D, Aman M, Esbensen A, Goodwin M, Dawson G, Hendren R, Leventhal B, Opler M, Ho KF, Pandina G. 177. Autism Behavior Inventory – A Novel Tool for Assessment of Changes in Core and Associated Symptoms of Autism Spectrum Disorder Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.190  0.7
2016 Lecavalier L, Smith T, Johnson C, Bearss K, Swiezy N, Aman MG, Sukhodolsky DG, Deng Y, Dziura J, Scahill L. Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder. Journal of Abnormal Child Psychology. PMID 27917460 DOI: 10.1007/S10802-016-0233-X  0.424
2016 Scahill L, Bearss K, Sarhangian R, McDougle CJ, Arnold LE, Aman MG, McCracken JT, Tierney E, Gillespie S, Postorino V, Vitiello B. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27893955 DOI: 10.1089/Cap.2016.0107  0.424
2016 Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27726426 DOI: 10.1089/Cap.2016.0090  0.397
2016 Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR, Brown NV, Pan X, Handen BL. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 868-876.e2. PMID 27663942 DOI: 10.1016/J.Jaac.2016.06.015  0.749
2016 Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, et al. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27556593 DOI: 10.1001/Jamapsychiatry.2016.1232  0.724
2016 Scahill L, Bearss K, Lecavalier L, Smith T, Swiezy N, Aman MG, Sukhodolsky DG, McCracken C, Minshawi N, Turner K, Levato L, Saulnier C, Dziura J, Johnson C. Effect of Parent Training on Adaptive Behavior in Children With Autism Spectrum Disorder and Disruptive Behavior: Results of a Randomized Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 602-609.e3. PMID 27343887 DOI: 10.1016/J.Jaac.2016.05.001  0.409
2016 Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, Scahill L. Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder. Sleep Medicine. 20: 5-11. PMID 27318219 DOI: 10.1016/J.Sleep.2015.12.005  0.438
2016 Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR, Schneider J, Aman MG. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 469-78. PMID 27238065 DOI: 10.1016/J.Jaac.2016.03.014  0.365
2016 Scahill L, Jeon S, Boorin SJ, McDougle CJ, Aman MG, Dziura J, McCracken JT, Caprio S, Arnold LE, Nicol G, Deng Y, Challa SA, Vitiello B. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 415-23. PMID 27126856 DOI: 10.1016/J.Jaac.2016.02.016  0.341
2016 Aman MG, Findling RL, Hardan AY, Hendren RL, Melmed RD, Kehinde-Nelson O, Hsu HA, Trugman JM, Palmer RH, Graham SM, Gage AT, Perhach JL, Katz E. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension. Journal of Child and Adolescent Psychopharmacology. PMID 26978327 DOI: 10.1089/Cap.2015.0146  0.348
2016 Hollway JA, Aman MG, Mendoza-Burcham MI, Silverman L, Arnold LE, Tumuluru R, Handen BL, Lecavalier L, Page K, Sayre P, Smith T. Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26797318 DOI: 10.1089/Cap.2015.0130  0.74
2016 Farmer CA, Kaat AJ, Mazurek MO, Lainhart JE, DeWitt MB, Cook EH, Butter EM, Aman MG. Confirmation of the Factor Structure and Measurement Invariance of the Children's Scale of Hostility and Aggression: Reactive/Proactive in Clinic-Referred Children with and without Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26744772 DOI: 10.1089/Cap.2015.0098  0.362
2016 Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, Scahill L. Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder Sleep Medicine. 20: 5-11. DOI: 10.1016/j.sleep.2015.12.005  0.329
2016 Bangerter A, Ness S, Ho KF, Aman MG, Esbensen A, Goodwin MS, Dawson G, Hendren RL, Leventhal BL, Opler M, Pandina GJ. 1.29 THE AUTISM BEHAVIOR INVENTORY: A NOVEL TOOL FOR ASSESSING CHANGE IN CORE AND ASSOCIATED SYMPTOMS OF AUTISM SPECTRUM DISORDER Journal of the American Academy of Child & Adolescent Psychiatry. 55: S109. DOI: 10.1016/J.Jaac.2016.09.030  0.674
2016 Grondhuis SN, Aman MG. Risk Factors for Overweight in Children with Autism Spectrum Disorder Journal of Developmental and Physical Disabilities. 29: 241-263. DOI: 10.1007/S10882-016-9522-0  0.816
2015 Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR, Hellings J, Mruzek DW, et al. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 905-15. PMID 26506581 DOI: 10.1016/J.Jaac.2015.08.013  0.743
2015 Kaat A, Farmer C, Gadow K, Findling RL, Bukstein O, Arnold LE, Bangalore S, McNamara N, Aman M. Factor Validity of a Proactive and Reactive Aggression Rating Scale. Journal of Child and Family Studies. 24: 2734-2744. PMID 26504369 DOI: 10.1007/S10826-014-0075-5  0.347
2015 Bearss K, Taylor CA, Aman MG, Whittemore R, Lecavalier L, Miller J, Pritchett J, Green B, Scahill L. Using qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. PMID 26395234 DOI: 10.1177/1362361315601012  0.401
2015 Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, et al. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25: 482-93. PMID 26262903 DOI: 10.1089/Cap.2015.0005  0.696
2015 Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder. Autism : the International Journal of Research and Practice. PMID 26187059 DOI: 10.1177/1362361315593941  0.673
2015 Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. Journal of Child and Adolescent Psychopharmacology. 25: 282-5. PMID 25978740 DOI: 10.1089/Cap.2015.28999.Mga  0.734
2015 Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, McAdam DB, Butter E, Stillitano C, Minshawi N, Sukhodolsky DG, Mruzek DW, Turner K, Neal T, Hallett V, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. Jama. 313: 1524-33. PMID 25898050 DOI: 10.1001/Jama.2015.3150  0.516
2015 Farmer CA, Brown NV, Gadow KD, Arnold LE, Kolko DG, Findling RL, Molina BS, Buchan-Page KA, Rice RR, Bangalore SS, Bukstein O, Rundberg-Rivera EV, McNamara N, Aman MG. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 25: 213-24. PMID 25885011 DOI: 10.1089/Cap.2014.0109  0.387
2015 Arnold LE, Gadow KD, Farmer CA, Findling RL, Bukstein O, Molina BS, Brown NV, Li X, Rundberg-Rivera EV, Bangalore S, Buchan-Page K, Hurt EA, Rice R, McNamara NK, Aman MG. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. Journal of Child and Adolescent Psychopharmacology. 25: 203-12. PMID 25885010 DOI: 10.1089/Cap.2014.0104  0.337
2015 Aman MG. Treatment of Severe Childhood Aggression (TOSCA) Studies. Journal of Child and Adolescent Psychopharmacology. 25: 201-2. PMID 25885009 DOI: 10.1089/Cap.2015.2532  0.322
2015 Scahill L, Sukhodolsky DG, Anderberg E, Dimitropoulos A, Dziura J, Aman MG, McCracken J, Tierney E, Hallett V, Katz K, Vitiello B, McDougle C. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials. Autism : the International Journal of Research and Practice. PMID 25882391 DOI: 10.1177/1362361315574889  0.398
2015 Farmer C, Butter E, Mazurek MO, Cowan C, Lainhart J, Cook EH, DeWitt MB, Aman M. Aggression in children with autism spectrum disorders and a clinic-referred comparison group. Autism : the International Journal of Research and Practice. 19: 281-91. PMID 24497627 DOI: 10.1177/1362361313518995  0.439
2015 Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, et al. Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. 19: 38-52. PMID 24259748 DOI: 10.1177/1362361313510069  0.815
2014 Silverman L, Hollway JA, Smith T, Aman MG, Arnold LE, Pan X, Li X, Handen BL. A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges. Research in Autism Spectrum Disorders. 8: 899-907. PMID 25197320 DOI: 10.1016/J.Rasd.2014.03.013  0.751
2014 Matlock ST, Aman MG. Psychometric characteristics of the adult scale of hostility and aggression: reactive/proactive (A-SHARP) and relation to psychiatric features of adults with developmental disabilities. Research in Developmental Disabilities. 35: 3199-207. PMID 25155742 DOI: 10.1016/J.Ridd.2014.07.029  0.778
2014 Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR, ... Aman MG, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 948-959.e1. PMID 25151418 DOI: 10.1016/J.Jaac.2014.05.008  0.808
2014 Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. A review of atomoxetine effects in young people with developmental disabilities. Research in Developmental Disabilities. 35: 1412-24. PMID 24732041 DOI: 10.1016/J.Ridd.2014.03.006  0.727
2014 Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 97-107.e1. PMID 24342389 DOI: 10.1016/J.Jaac.2013.09.018  0.427
2014 Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, Rundberg-Rivera EV, Li X, Kipp H, Schneider J, Butter EM, Baker J, Sprafkin J, Rice RR, Bangalore SS, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 53: 47-60.e1. PMID 24342385 DOI: 10.1016/J.Jaac.2013.09.022  0.807
2014 Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child and Adolescent Psychiatric Clinics of North America. 23: 57-72. PMID 24231167 DOI: 10.1016/J.Chc.2013.08.002  0.403
2014 Kaat AJ, Lecavalier L, Aman MG. Validity of the aberrant behavior checklist in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1103-16. PMID 24165702 DOI: 10.1007/S10803-013-1970-0  0.416
2014 Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, et al. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1128-43. PMID 24158679 DOI: 10.1007/S10803-013-1974-9  0.803
2014 Grondhuis SN, Aman MG. Overweight and obesity in youth with developmental disabilities: a call to action. Journal of Intellectual Disability Research : Jidr. 58: 787-99. PMID 24020517 DOI: 10.1111/Jir.12090  0.771
2014 McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL. Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders Pharmacogenomics Journal. 14: 295-302. PMID 23856854 DOI: 10.1038/Tpj.2013.23  0.353
2013 Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. Journal of Child and Adolescent Psychopharmacology. 23: 337-51. PMID 23782128 DOI: 10.1089/Cap.2012.0096  0.342
2013 Bearss K, Lecavalier L, Minshawi N, Johnson C, Smith T, Handen B, Sukhodolsky D, Aman M, Swiezy N, Butter E, Scahill L. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry. 3: 169-180. PMID 23772233 DOI: 10.2217/npy.13.14  0.414
2013 Handen BL, Johnson CR, Butter EM, Lecavalier L, Scahill L, Aman MG, McDougle CJ, Arnold LE, Swiezy NB, Sukhodolsky DG, Mulick JA, White SW, Bearss K, Hollway JA, Stigler KA, et al. Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders. Journal of Developmental and Physical Disabilities. 25: 355-371. PMID 23730123 DOI: 10.1007/S10882-012-9316-Y  0.696
2013 Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network. Journal of Autism and Developmental Disorders. 43: 2830-43. PMID 23624832 DOI: 10.1007/S10803-013-1830-Y  0.686
2013 Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/S10803-013-1775-1  0.358
2013 Arnold LE, Anand R, Aman M. Varenicline in autistic disorder: hypothesis and case report of single-patient crossover. Journal of Child and Adolescent Psychopharmacology. 23: 61-4. PMID 23350866 DOI: 10.1089/Cap.2012.0025  0.336
2013 Kent JM, Kushner S, Ning X, Karcher K, Ness S, Aman M, Singh J, Hough D. Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study. Journal of Autism and Developmental Disorders. 43: 1773-83. PMID 23212807 DOI: 10.1007/S10803-012-1723-5  0.341
2013 Farmer CA, Aman MG. Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities: The Glass is Half Full International Review of Research in Developmental Disabilities. 44: 281-325. DOI: 10.1016/B978-0-12-401662-0.00009-9  0.326
2012 Arnold LE, Aman MG, Li X, Butter E, Humphries K, Scahill L, Lecavalier L, McDougle CJ, Swiezy NB, Handen B, Wilson K, Stigler KA. Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 1173-84. PMID 23101743 DOI: 10.1016/J.Jaac.2012.08.028  0.316
2012 Pearson DA, Aman MG, Arnold LE, Lane DM, Loveland KA, Santos CW, Casat CD, Mansour R, Jerger SW, Ezzell S, Factor P, Vanwoerden S, Ye E, Narain P, Cleveland LA. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 284-91. PMID 22849541 DOI: 10.1089/Cap.2011.0067  0.399
2012 Arnold LE, Aman MG, Hollway J, Hurt E, Bates B, Li X, Farmer C, Anand R, Thompson S, Ramadan Y, Williams C. Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 198-205. PMID 22537359 DOI: 10.1089/Cap.2011.0056  0.661
2012 Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 136-46. PMID 22265360 DOI: 10.1016/J.Jaac.2011.11.010  0.739
2012 Farmer C, Lecavalier L, Yu S, Eugene Arnold L, McDougle CJ, Scahill L, Handen B, Johnson CR, Stigler KA, Bearss K, Swiezy NB, Aman MG. Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems. Journal of Autism and Developmental Disorders. 42: 1037-44. PMID 21822762 DOI: 10.1007/S10803-011-1338-2  0.413
2012 Grondhuis SN, Aman MG. Assessment of anxiety in children and adolescents with autism spectrum disorders Research in Autism Spectrum Disorders. 6: 1345-1365. DOI: 10.1016/J.Rasd.2012.04.006  0.828
2011 Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Corey-Lisle PK, Aman MG. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. Journal of Child and Adolescent Psychopharmacology. 21: 229-36. PMID 21663425 DOI: 10.1089/Cap.2009.0121  0.305
2011 Hollway JA, Aman MG. Sleep correlates of pervasive developmental disorders: a review of the literature. Research in Developmental Disabilities. 32: 1399-421. PMID 21570809 DOI: 10.1016/J.Ridd.2011.04.001  0.672
2011 Matlock ST, Aman MG. Development of the Adult Scale of Hostility and Aggression: Reactive-Proactive (A-SHARP). American Journal On Intellectual and Developmental Disabilities. 116: 130-41. PMID 21381948 DOI: 10.1352/1944-7558-116.2.130  0.766
2011 Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in Developmental Disabilities. 32: 939-62. PMID 21296553 DOI: 10.1016/J.Ridd.2010.12.035  0.665
2011 Farmer CA, Aman MG. Aripiprazole for the treatment of irritability associated with autism. Expert Opinion On Pharmacotherapy. 12: 635-40. PMID 21294670 DOI: 10.1517/14656566.2011.557661  0.363
2011 Farmer CA, Aman MG. Aggressive behavior in a sample of children with autism spectrum disorders Research in Autism Spectrum Disorders. 5: 317-323. DOI: 10.1016/J.Rasd.2010.04.014  0.417
2010 Reid JM, Storch EA, Murphy TK, Bodzin D, Mutch PJ, Lehmkuhl H, Aman M, Goodman WK. Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile. Child & Youth Care Forum. 39: 113-124. PMID 20473344 DOI: 10.1007/S10566-010-9095-5  0.408
2010 Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB. Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. Journal of Child and Adolescent Psychopharmacology. 20: 83-93. PMID 20415603 DOI: 10.1089/Cap.2009.0022  0.317
2010 Chowdhury M, Aman MG, Scahill L, Swiezy N, Arnold LE, Lecavalier L, Johnson C, Handen B, Stigler K, Bearss K, Sukhodolsky D, McDougle CJ. The Home Situations Questionnaire-PDD version: factor structure and psychometric properties. Journal of Intellectual Disability Research : Jidr. 54: 281-91. PMID 20377705 DOI: 10.1111/J.1365-2788.2010.01259.X  0.621
2010 McCracken JT, Aman MG, McDougle CJ, Tierney E, Shiraga S, Whelan F, Arnold LE, Posey D, Ritz L, Vitiello B, Scahill L. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. Journal of Child and Adolescent Psychopharmacology. 20: 1-5. PMID 20166790 DOI: 10.1089/cap.2009.0059  0.362
2010 Farmer CA, Aman MG. Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 31: 270-80. PMID 19854027 DOI: 10.1016/J.Ridd.2009.09.014  0.382
2010 Aman MG, Arnold LE, Lecavalier L, Hollway JA, Mulick JA, McDougle CJ, Swiezy NB, Stigler KA, Handen BL, Johnson C, Vitiello B, Bearss K, Dziura J, Scahill L. Dr. Aman et al. reply Journal of the American Academy of Child and Adolescent Psychiatry. 49: 407-408. DOI: 10.1097/00004583-201004000-00016  0.581
2009 Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1143-54. PMID 19858761 DOI: 10.1097/Chi.0B013E3181Bfd669  0.741
2009 Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1110-9. PMID 19797985 DOI: 10.1097/Chi.0B013E3181B76658  0.356
2009 Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. Journal of Child and Adolescent Psychopharmacology. 19: 329-39. PMID 19702485 DOI: 10.1089/Cap.2008.0137  0.323
2009 Esbensen AJ, Greenberg JS, Seltzer MM, Aman MG. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders. 39: 1339-49. PMID 19434487 DOI: 10.1007/S10803-009-0750-3  0.584
2009 Farmer CA, Aman MG. Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 30: 1155-67. PMID 19375274 DOI: 10.1016/J.Ridd.2009.03.001  0.32
2009 Ghuman JK, Aman MG, Ghuman HS, Reichenbacher T, Gelenberg A, Wright R, Rice S, Fort C. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 19: 155-66. PMID 19364293 DOI: 10.1089/Cap.2008.054  0.363
2009 Handen BL, Melmed RD, Hansen RL, Aman MG, Burnham DL, Bruss JB, McDougle CJ. A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. Journal of Autism and Developmental Disorders. 39: 796-805. PMID 19148734 DOI: 10.1007/S10803-008-0687-Y  0.348
2009 Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 405-13. PMID 18791817 DOI: 10.1007/S10803-008-0637-8  0.338
2009 Aman MG, Hollway JA, Leone S, Masty J, Lindsay R, Nash P, Arnold LE. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Research in Developmental Disabilities. 30: 386-96. PMID 18768293 DOI: 10.1016/J.Ridd.2008.07.004  0.664
2009 Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. Journal of Autism and Developmental Disorders. 39: 395-404. PMID 18752063 DOI: 10.1007/S10803-008-0636-9  0.331
2009 Karabekiroglu K, Aman MG. Validity of the aberrant behavior checklist in a clinical sample of toddlers. Child Psychiatry and Human Development. 40: 99-110. PMID 18600444 DOI: 10.1007/S10578-008-0108-7  0.393
2008 Aman MG, Farmer CA, Hollway J, Arnold LE. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 713-38, vii. PMID 18775366 DOI: 10.1016/J.Chc.2008.06.009  0.701
2008 Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, et al. Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology. 18: 227-36. PMID 18582177 DOI: 10.1089/Cap.2007.0133  0.693
2008 Aman M, Leone S, Lecavalier L, Park L, Buican B, Coury D. The Nisonger Child Behavior Rating Form: typical IQ version. International Clinical Psychopharmacology. 23: 232-42. PMID 18545062 DOI: 10.1097/Yic.0B013E3282F94Ad0  0.504
2008 Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology. 36: 117-28. PMID 17674186 DOI: 10.1007/S10802-007-9165-9  0.401
2007 Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biological Psychiatry. 61: 538-44. PMID 17276750 DOI: 10.1016/J.Biopsych.2006.09.028  0.358
2007 Wagner A, Lecavalier L, Arnold LE, Aman MG, Scahill L, Stigler KA, Johnson CR, McDougle CJ, Vitiello B. Developmental disabilities modification of the Children's Global Assessment Scale. Biological Psychiatry. 61: 504-11. PMID 17276748 DOI: 10.1016/J.Biopsych.2007.01.001  0.345
2007 Pandina GJ, Bilder R, Harvey PD, Keefe RSE, Aman MG, Gharabawi G. Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders Biological Psychiatry. 62: 226-234. PMID 17210137 DOI: 10.1016/J.Biopsych.2006.09.036  0.344
2007 Tierney E, Aman M, Stout D, Pappas K, Arnold LE, Vitiello B, Scahill L, McDougle C, McCracken J, Wheeler C, Martin A, Posey D, Shah B. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology. 191: 149-57. PMID 17123125 DOI: 10.1007/S00213-006-0604-Z  0.365
2007 Lam KS, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders. 37: 855-66. PMID 17048092 DOI: 10.1007/S10803-006-0213-Z  0.594
2007 Johnson CR, Handen BL, Butter E, Wagner A, Mulick J, Sukhodolsky DG, Williams S, Swiezy NA, Arnold LE, Aman MG, Scahill L, Stigler KA, McDougle CJ, Vitiello B, Smith T. Development of a parent training program for children with pervasive developmental disorders Behavioral Interventions. 22: 201-221. DOI: 10.1002/Bin.237  0.339
2006 Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. A prospective open trial of guanfacine in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 16: 589-98. PMID 17069547 DOI: 10.1089/Cap.2006.16.589  0.383
2006 Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1196-205. PMID 17003665 DOI: 10.1097/01.Chi.0000231976.28719.2A  0.374
2006 Pandina GJ, Aman MG, Findling RL. Risperidone in the management of disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology. 16: 379-92. PMID 16958564 DOI: 10.1089/Cap.2006.16.379  0.356
2006 Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, et al. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1114-23. PMID 16926619 DOI: 10.1097/01.Chi.0000220854.79144.E7  0.637
2006 Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, et al. Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 431-9. PMID 16601648 DOI: 10.1097/01.Chi.0000196423.80717.32  0.722
2006 Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, et al. Validity of the autism diagnostic interview-revised. American Journal of Mental Retardation : Ajmr. 111: 199-215. PMID 16597187 DOI: 10.1352/0895-8017(2006)111[199:Votadi]2.0.Co;2  0.664
2006 Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Research in Developmental Disabilities. 27: 254-89. PMID 16002261 DOI: 10.1016/J.Ridd.2005.03.003  0.571
2005 Lord C, Wagner A, Rogers S, Szatmari P, Aman M, Charman T, Dawson G, Durand VM, Grossman L, Guthrie D, Harris S, Kasari C, Marcus L, Murphy S, Odom S, et al. Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders. Journal of Autism and Developmental Disorders. 35: 695-708; discussion . PMID 16496206 DOI: 10.1007/S10803-005-0017-6  0.346
2005 Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L, Tierney E, Posey DJ, Swiezy NB, Koenig K. Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone. Journal of Clinical Psychopharmacology. 25: 565-9. PMID 16282839 DOI: 10.1097/01.Jcp.0000185426.08268.92  0.318
2005 Posey DJ, Aman MG, Arnold LE, Ramadan Y, Witwer A, Lindsay R, McDougle CJ, Swiezy N, Kohn A, McCracken JT, Shah B, Cronin P, McGough J, Lee LSY, Scahill L, et al. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Archives of General Psychiatry. 62: 1266-1274. PMID 16275814 DOI: 10.1001/Archpsyc.62.11.1266  0.379
2005 LeBlanc JC, Binder CE, Armenteros JL, Aman MG, Wang JS, Hew H, Kusumakar V. Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials. International Clinical Psychopharmacology. 20: 275-83. PMID 16096518 DOI: 10.1097/01.Yic.0000166403.03732.72  0.32
2005 Correia Filho AG, Bodanese R, Silva TL, Alvares JP, Aman M, Rohde LA. Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 748-55. PMID 16034276 DOI: 10.1097/01.chi.0000166986.30592.67  0.323
2005 McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry. 162: 1142-8. PMID 15930063 DOI: 10.1176/Appi.Ajp.162.6.1142  0.725
2005 Aman M, Buitelaar J, Smedt GD, Wapenaar R, Binder C. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ. Journal of Child and Adolescent Psychopharmacology. 15: 220-32. PMID 15910206 DOI: 10.1089/Cap.2005.15.220  0.514
2005 Neef NA, Marckel J, Ferreri SJ, Bicard DF, Endo S, Aman MG, Miller KM, Jung S, Nist L, Armstrong N. Behavioral assessment of impulsivity: a comparison of children with and without attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 23-37. PMID 15898472 DOI: 10.1901/Jaba.2005.146-02  0.357
2005 Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology. 15: 116-26. PMID 15741793 DOI: 10.1089/Cap.2005.15.116  0.528
2004 Lecavalier L, Aman MG, Hammer D, Stoica W, Mathews GL. Factor analysis of the Nisonger Child Behavior Rating Form in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 34: 709-21. PMID 15679190 DOI: 10.1007/S10803-004-5291-1  0.376
2004 Aman MG, Binder C, Turgay A. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology. 14: 243-54. PMID 15319021 DOI: 10.1089/1044546041649020  0.388
2004 Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. The American Journal of Psychiatry. 161: 677-84. PMID 15056514 DOI: 10.1176/Appi.Ajp.161.4.677  0.326
2004 Shultz J, Aman M, Kelbley T, LeClear Wallace C, Burt DB, Primeaux-Hart S, Loveland K, Thorpe L, Bogos ES, Timon J, Patti P, Tsiouris J. Evaluation of screening tools for dementia in older adults with mental retardation. American Journal of Mental Retardation : Ajmr. 109: 98-110. PMID 15000667 DOI: 10.1352/0895-8017(2004)109<98:Eostfd>2.0.Co;2  0.629
2004 Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Outcome measures for clinical drug trials in autism. Cns Spectrums. 9: 36-47. PMID 14999174 DOI: 10.1017/S1092852900008348  0.307
2004 Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 11-28. PMID 14659983 DOI: 10.1016/S0924-977X(03)00045-2  0.417
2003 Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders. 33: 617-29. PMID 14714931 DOI: 10.1023/B:Jadd.0000005999.27178.55  0.73
2003 Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1443-50. PMID 14627879 DOI: 10.1097/00004583-200312000-00011  0.671
2003 Lindsay RL, Aman MG. Pharmacologic therapies aid treatment for autism. Pediatric Annals. 32: 671-6. PMID 14606217 DOI: 10.3928/0090-4481-20031001-08  0.334
2003 Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders. 33: 527-34. PMID 14594332 DOI: 10.1023/A:1025883612879  0.527
2003 Rojahn J, Aman MG, Matson JL, Mayville E. The Aberrant Behavior Checklist and the Behavior Problems Inventory: convergent and divergent validity. Research in Developmental Disabilities. 24: 391-404. PMID 12951135 DOI: 10.1016/S0891-4222(03)00055-6  0.615
2003 Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology. 13: 29-40. PMID 12804124 DOI: 10.1089/104454603321666171  0.352
2003 Aman MG, Lindsay RL. Psychotropic Medicines and Aggressive Behavior Part II: Antipsychotics and Mood Stabilizers Child and Adolescent Psychopharmacology News. 8: 6-12. DOI: 10.1521/Capn.8.2.6.23068  0.324
2003 Findling R, Aman M, Kusumakar V, Daneman D, Moshang T, Smedt GD, Binder C. Prolactin levels in children after long term treatment with risperidone Schizophrenia Research. 60: 354-355. DOI: 10.1016/S0920-9964(03)80161-5  0.322
2002 Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 1026-36. PMID 12218423 DOI: 10.1097/00004583-200209000-00002  0.518
2002 McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, et al. Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine. 347: 314-21. PMID 12151468 DOI: 10.1056/Nejmoa013171  0.708
2002 Aman MG, Armstrong S, Buican B, Sillick T. Four-year follow-up of children with low intelligence and ADHD: a replication. Research in Developmental Disabilities. 23: 119-134. PMID 12061750 DOI: 10.1016/S0891-4222(02)00090-2  0.385
2001 Scahill L, McCracken J, McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, et al. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. Journal of Child and Adolescent Psychopharmacology. 11: 377-88. PMID 11838820 DOI: 10.1089/104454601317261555  0.433
2001 Turgay A, Aman MG, Binder C. Risperidone in children with various disruptive behavior disorders, subaverage IQ and comorbid ADHD European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80299-6  0.399
2001 Aman MG. Antipsychotics and disruptive disorders in children European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80026-2  0.363
2000 Aman MG, Collier-Crespin A, Lindsay RL. Pharmacotherapy of disorders in mental retardation European Child and Adolescent Psychiatry. 9. PMID 11140785 DOI: 10.1007/S007870070023  0.328
2000 Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ, McGough JJ, Posey DJ, et al. Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology. Journal of Autism and Developmental Disorders. 30: 99-111. PMID 10832774 DOI: 10.1023/A:1005451304303  0.337
2000 Aman M, Findling R, Derivan A. 490. Risperidone versus placebo for severe conduct disorder in children with mental retardation Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00760-5  0.448
1998 Shultz JM, Aman MG, Rojahn J. Psychometric evaluation of a measure of cognitive decline in elderly people with mental retardation. Research in Developmental Disabilities. 19: 63-71. PMID 9472135 DOI: 10.1016/S0891-4222(97)00029-2  0.72
1997 DeWitt MB, Aman MG, Rojahn J. Effects of Reinforcement Contingencies on Performance of Children with Mental Retardation and Attention Problems Journal of Developmental and Physical Disabilities. 9: 101-115. DOI: 10.1023/A:1024973618256  0.631
1996 Aman MG, Pejeau C, Osborne P, Rojahn J, Handen B. Four-year follow-up of children with low intelligence and ADHD. Research in Developmental Disabilities. 17: 417-32. PMID 8946568 DOI: 10.1016/S0891-4222(96)00023-6  0.679
1996 Tassé MJ, Aman MG, Hammer D, Rojahn J. The Nisonger child behavior rating form: Age and gender effects and norms Research in Developmental Disabilities. 17: 59-75. PMID 8750076 DOI: 10.1016/0891-4222(95)00037-2  0.636
1996 Aman MG, Tassé MJ, Rojahn J, Hammer D. The Nisonger CBRF: A child behavior rating form for children with developmental disabilities Research in Developmental Disabilities. 17: 41-57. PMID 8750075 DOI: 10.1016/0891-4222(95)00039-9  0.66
1996 Sarphare G, Aman MG. Parent- and self-ratings of anxiety in children with mental retardation: Agreement levels and test-retest reliability Research in Developmental Disabilities. 17: 27-39. PMID 8750074 DOI: 10.1016/0891-4222(95)00035-6  0.344
1996 Aman MG. Stimulant drugs in the developmental disabilities revisited Journal of Developmental and Physical Disabilities. 8: 347-365. DOI: 10.1007/Bf02578400  0.31
1995 Einfeld SL, Aman M. Issues in the taxonomy of psychopathology in mental retardation Journal of Autism and Developmental Disorders. 25: 143-167. PMID 7559282 DOI: 10.1007/Bf02178501  0.373
1994 Pearson DA, Aman MG. Ratings of hyperactivity and developmental indices: Should clinicians correct for developmental level? Journal of Autism and Developmental Disorders. 24: 395-411. PMID 7525533 DOI: 10.1007/Bf02172125  0.309
1994 Aman MG, Rojahn J, King EH, Logsdon DA, Marshburn EC. Prevalence and pattern of prescribed medication in 2-year-old children Journal of Developmental and Physical Disabilities. 6: 87-99. DOI: 10.1007/Bf02579352  0.578
1994 Aman MG, Rojahn J. The psychometric characteristics of the preschool behavior questionnaire in preschoolers with developmental handicaps Journal of Developmental and Physical Disabilities. 6: 311-325. DOI: 10.1007/Bf02578418  0.621
1993 Aman MG, Kern RA, McGHEE DE, Arnold LE. Fenfluramine and Methylphenidate in Children with Mental Retardation and ADHD: Clinical and Side Effects Journal of the American Academy of Child and Adolescent Psychiatry. 32: 851-859. PMID 8340309 DOI: 10.1097/00004583-199307000-00022  0.355
1993 Aman MG, Kern RA, McGhee DE, Arnold LE. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects Journal of Autism and Developmental Disorders. 23: 491-506. PMID 8226583 DOI: 10.1007/Bf01046052  0.304
1991 Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. Clinical Effects of Methylphenidate and Thioridazine in Intellectually Subaverage Children Journal of the American Academy of Child and Adolescent Psychiatry. 30: 246-256. PMID 2016229 DOI: 10.1097/00004583-199103000-00013  0.345
1984 Aman MG. Hyperactivity: Nature of the syndrome and its natural history Journal of Autism and Developmental Disorders. 14: 39-56. PMID 6368521 DOI: 10.1007/Bf02408554  0.366
1984 Aman MG, Werry JS. The revised behavior problem checklist in clinic attenders and non‐attenders: Age and sex effects Journal of Clinical Child Psychology. 13: 237-242. DOI: 10.1080/15374418409533196  0.335
1983 Aman MG, Werry JS, Fitzpatrick J, Lowe M, Waters J. Factor Structure and Norms for the Revised Behavior Problem Checklist in New Zealand Children Australian and New Zealand Journal of Psychiatry. 17: 354-360. PMID 6581794 DOI: 10.1080/00048678309160013  0.323
1976 Werry JS, Aman MG. The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS) Journal of Autism and Childhood Schizophrenia. 6: 253-262. PMID 1036492 DOI: 10.1007/Bf01543465  0.303
Low-probability matches (unlikely to be authored by this person)
2017 Kwok MA, Arnold LE, Barterian J, Pan X, Scahill L, Aman M, McDougle C. 5.9 Evaluating the Relationship Between the Vineland Adaptive Behavior Scale and the Assessment of Basic Language and Learning Skills-Modified Journal of the American Academy of Child & Adolescent Psychiatry. 56: S255-S256. DOI: 10.1016/J.Jaac.2017.09.292  0.3
1982 Aman MG, Werry JS. Children's reading disorders: Problems of definition and a two-year follow-up Australian Paediatric Journal. 18: 268-272. PMID 7165590  0.299
2004 Aman MG, Gharabawi GM. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. The Journal of Clinical Psychiatry. 65: 1197-210. PMID 15367046 DOI: 10.4088/Jcp.V65N0907  0.298
2002 Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry. 159: 1337-46. PMID 12153826 DOI: 10.1176/Appi.Ajp.159.8.1337  0.298
2023 Hough D, Mao AR, Aman M, Lozano R, Smith-Hicks C, Martinez-Cerdeno V, Derby M, Rome Z, Malan N, Findling RL. Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder. Annals of General Psychiatry. 22: 45. PMID 37932739 DOI: 10.1186/s12991-023-00477-8  0.293
1980 Aman MG, Singh NN. The usefulness of thioridazine for treating childhood disorders - fact or folklore? American Journal of Mental Deficiency. 84: 331-338. PMID 6986772  0.292
1991 Arnold LE, Aman MG. Beta blockers in mental retardation and developmental disorders. Journal of Child and Adolescent Psychopharmacology. 1: 361-373. PMID 19630686 DOI: 10.1089/Cap.1991.1.361  0.292
2002 Brown EC, Aman MG, Havercamp SM. Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Research in Developmental Disabilities. 23: 45-60. PMID 12071395 DOI: 10.1016/S0891-4222(01)00091-9  0.291
1982 Aman MG. Stimulant drug effects in developmental disorders and hyperactivity - Toward a resolution of disparate findings Journal of Autism and Developmental Disorders. 12: 385-398. PMID 6131061 DOI: 10.1007/Bf01538326  0.289
2002 Aman MG, Lindsay RL. Psychotropic Medicines and Aggressive Behavior Child and Adolescent Psychopharmacology News. 7: 1-6. DOI: 10.1521/Capn.7.5.1.22725  0.283
2009 Johnson CR, Butter EM, Handen BL, Sukhodolsky DG, Mulick J, Lecavalier L, Aman MG, Arnold LE, Scahill L, Swiezy N, Sacco K, Stigler KA, McDougle CJ. Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials. Journal of Intellectual & Developmental Disability. 34: 230-8. PMID 19681003 DOI: 10.1080/13668250903074471  0.283
1989 Aman MG, Kern RA. Review of fenfluramine in the treatment of the developmental disabilities Journal of the American Academy of Child and Adolescent Psychiatry. 28: 549. PMID 2670881 DOI: 10.1097/00004583-198907000-00014  0.28
2020 Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 32644833 DOI: 10.1089/Cap.2020.0004  0.28
2008 Aman MG, Farmer CA. Psychotropic medication research in children and adolescents: empirical findings and ethical implications. Journal of Empirical Research On Human Research Ethics : Jerhre. 3: 39-47. PMID 19385769 DOI: 10.1525/Jer.2008.3.3.39  0.278
1984 Aman MG, Vamos M, Werry JS. Effects of methylphenidate in normal adults with reference to drug action in hyperactivity Australian and New Zealand Journal of Psychiatry. 18: 86-88. PMID 6380485 DOI: 10.3109/00048678409161040  0.277
1999 Aman MG, Arnold LE, Armstrong SC. Review of serotonergic agents and perseverative behavior in patients with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 279-289. DOI: 10.1002/(Sici)1098-2779(1999)5:4<279::Aid-Mrdd5>3.0.Co;2-6  0.276
2006 Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study. Journal of Intellectual & Developmental Disability. 31: 204-9. PMID 17178532 DOI: 10.1080/13668250601006924  0.276
2004 Martin A, Scahill L, Anderson GM, Aman M, Arnold LE, McCracken J, McDougle CJ, Tierney E, Chuang S, Vitiello B. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. The American Journal of Psychiatry. 161: 1125-7. PMID 15169706 DOI: 10.1176/Appi.Ajp.161.6.1125  0.275
2005 Aman MG. Treatment planning for patients with autism spectrum disorders. The Journal of Clinical Psychiatry. 66: 38-45. PMID 16401149  0.275
2000 Aman MG, Armstrong SA. Regarding secretin for treating autistic disorder [1] Journal of Autism and Developmental Disorders. 30: 71-72. PMID 10819123  0.273
2005 Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, et al. Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology. 15: 869-84. PMID 16379507 DOI: 10.1089/Cap.2005.15.869  0.273
2009 Scahill L, Aman MG, McDougle CJ, Arnold LE, McCracken JT, Handen B, Johnson C, Dziura J, Butter E, Sukhodolsky D, Swiezy N, Mulick J, Stigler K, Bearss K, Ritz L, et al. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 720-9. PMID 19096921 DOI: 10.1007/S10803-008-0675-2  0.272
1999 Aman MG, Eugene Arnold L, Armstrong SC. Review of serotonergic agents and perseverative behavior in patients with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 279-289. DOI: 10.1002/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO;2-6  0.272
2015 Calarge CA, Ziegler EE, Del Castillo N, Aman M, McDougle CJ, Scahill L, McCracken JT, Arnold LE. Iron homeostasis during risperidone treatment in children and adolescents. The Journal of Clinical Psychiatry. PMID 26301448 DOI: 10.4088/Jcp.14M09258  0.272
2005 Neef NA, Bicard DF, Endo S, Coury DL, Aman MG. Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 135-46. PMID 16033162 DOI: 10.1901/Jaba.2005.116-02  0.271
1987 Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by efamol in hyperactive children Journal of Abnormal Child Psychology. 15: 75-90. PMID 3553274 DOI: 10.1007/Bf00916467  0.271
2015 Rundberg-Rivera EV, Townsend LD, Schneider J, Farmer CA, Molina BB, Findling RL, Gadow KD, Bukstein OG, Arnold LE, Kolko DJ, Buchan-Page KA, McNamara NK, Michel C, Austin A, Kipp H, ... Aman MG, et al. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression. Journal of Child and Adolescent Psychopharmacology. 25: 225-33. PMID 25885012 DOI: 10.1089/Cap.2014.0097  0.269
2013 Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, Tierney E, Deng Y, Dziura J, Vitiello B. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. Journal of Autism and Developmental Disorders. 43: 739-46. PMID 23104617 DOI: 10.1007/S10803-012-1689-3  0.269
2000 Aman MG, Langworthy KS. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders Journal of Autism and Developmental Disorders. 30: 451-459. PMID 11098883 DOI: 10.1023/A:1005559725475  0.268
2015 Hellings JA, Reed G, Cain SE, Zhou X, Barth FX, Aman MG, Palaguachi GI, Mikhnev D, Teng R, Andridge R, Logan M, Butler MG, Han JC. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. Journal of Child and Adolescent Psychopharmacology. 25: 150-9. PMID 25782098 DOI: 10.1089/Cap.2014.0003  0.267
2004 Aman MG. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Seminars in Pediatric Neurology. 11: 225-8. PMID 15575418 DOI: 10.1016/J.Spen.2004.07.006  0.261
1985 Sandberg S, Aman M. Comment on "hyperactivity: Nature of the syndrome and its natural history", Journal of Autism and Developmental Disorders. 15: 229-233. PMID 3997749 DOI: 10.1007/Bf01531608  0.259
2010 Aman MG, Kasper W, Manos G, Mathew S, Marcus R, Owen R, Mankoski R. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Journal of Child and Adolescent Psychopharmacology. 20: 415-22. PMID 20973712 DOI: 10.1089/Cap.2009.0120  0.256
2019 Hardan AY, Hendren RL, Aman MG, Robb A, Melmed RD, Andersen KA, Luchini R, Rahman R, Ali S, Jia XD, Mallick M, Lateiner JE, Palmer RH, Graham SM. Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. Autism : the International Journal of Research and Practice. 1362361318824103. PMID 31027422 DOI: 10.1177/1362361318824103  0.255
1999 Aman MG, Madrid A. Atypical antipsychotics in persons with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 253-263. DOI: 10.1002/(SICI)1098-2779(1999)5:4<253::AID-MRDD2>3.0.CO;2-R  0.254
1999 Aman MG, Madrid A. Atypical antipsychotics in persons with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 253-263. DOI: 10.1002/(Sici)1098-2779(1999)5:4<253::Aid-Mrdd2>3.0.Co;2-R  0.254
2002 Findling RL, Aman MG, Smedt GD, Derivan A. Risperidone in children with conduct problems and subaverage IQ European Psychiatry. 17: 118. DOI: 10.1016/S0924-9338(02)80524-7  0.252
1991 Aman MG, Turbott SH. Prediction of clinical response in children taking methylphenidate Journal of Autism and Developmental Disorders. 21: 211-228. PMID 1864828 DOI: 10.1007/Bf02284761  0.252
2012 Aman MG. Aberrant Behavior Checklist: Current Identity and Future Developments Clinical and Experimental Pharmacology. 2. DOI: 10.4172/2161-1459.1000E114  0.25
1995 Aman MG, Wolford PL. Consumer satisfaction with involvement in drug research: A social validity study Journal of the American Academy of Child and Adolescent Psychiatry. 34: 940-945. PMID 7649965 DOI: 10.1097/00004583-199507000-00018  0.25
1979 Aman MG. Cognitive, social, and other correlates of specific reading retardation Journal of Abnormal Child Psychology. 7: 153-168. PMID 469109 DOI: 10.1007/Bf00918896  0.246
2001 Findling RL, Aman MG, Smedt GD, Derivan A. Risperidone in children with significant conduct problems and subaverage intellectual functioning European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80298-4  0.244
2007 Jensen PS, Youngstrom EA, Steiner H, Findling RL, Meyer RE, Malone RP, Carlson GA, Coccaro EF, Aman MG, Blair J, Dougherty D, Ferris C, Flynn L, Green E, Hoagwood K, et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. Journal of the American Academy of Child and Adolescent Psychiatry. 46: 309-22. PMID 17314717 DOI: 10.1097/Chi.0B013E31802F1454  0.242
1982 Aman MG, Werry JS. Methylphenidate and diazepam in severe reading retardation Journal of the American Academy of Child and Adolescent Psychiatry. 21: 31-37.  0.241
2019 Halvorsen M, Aman MG, Mathiassen B, Brøndbo PH, Steinsvik OO, Martinussen M. Psychometric Properties of the Norwegian Aberrant Behavior Checklist and Diagnostic Relationships in a Neuro-pediatric Sample Journal of Mental Health Research in Intellectual Disabilities. 12: 234-255. DOI: 10.1080/19315864.2019.1630872  0.24
2007 Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biological Psychiatry. 61: 545-50. PMID 16730335 DOI: 10.1016/J.Biopsych.2006.02.032  0.239
2016 Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. Journal of Child and Adolescent Psychopharmacology. PMID 27348211 DOI: 10.1089/Cap.2016.0040  0.237
1992 Marshburn EC, Aman MG. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation Journal of Autism and Developmental Disorders. 22: 357-373. PMID 1383187 DOI: 10.1007/Bf01048240  0.237
1975 Aman MG, Werry JS. Methylphenidate in Children: Effects upon Cardiorespiratory Function on Exertion International Journal of Mental Health. 4: 119-131. DOI: 10.1080/00207411.1975.11448678  0.237
1986 Aman MG, White AJ, Vaithianathan C, Teehan CJ. Preliminary study of imipramine in profoundly retarded residents. Journal of Autism and Developmental Disorders. 16: 263-273. PMID 3549681 DOI: 10.1007/Bf01531659  0.236
2000 McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, et al. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child and Adolescent Psychiatric Clinics of North America. 9: 201-224. DOI: 10.1016/S1056-4993(18)30142-1  0.235
1987 Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children Clinical Pediatrics. 26: 406-411. PMID 2439249 DOI: 10.1177/000992288702600805  0.235
2002 Langworthy-Lam KS, Aman MG, Van Bourgondien ME. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology. 12: 311-21. PMID 12625991 DOI: 10.1089/104454602762599853  0.23
2013 Nurmi EL, Spilman SL, Whelan F, Scahill LL, Aman MG, McDougle CJ, Arnold LE, Handen B, Johnson C, Sukhodolsky DG, Posey DJ, Lecavalier L, Stigler KA, Ritz L, Tierney E, et al. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies Translational Psychiatry. 3. PMID 23799528 DOI: 10.1038/Tp.2013.26  0.229
1976 Werry JS, Aman MG, Lampen E. Haloperidol and methylphenidate in hyperactive children Acta Paedopsychiatrica. 42: 26-40. PMID 775883  0.229
1988 Dura JR, Aman MG, Mulick JA. Medication use in an ICF/MR for nonambulatory severely and profoundly mentally retarded children Journal of the Multihandicapped Person. 1: 155-160. DOI: 10.1007/BF01102620  0.229
2003 McDougle CJ, Aman MG, McCracken JT, Scahill L, Tierney E, Vitiello B. P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)92062-1  0.227
1975 Werry JS, Aman MG. Methylphenidate and Haloperidol in Children: Effects on Attention, Memory, and Activity Archives of General Psychiatry. 32: 790-795. PMID 1093506 DOI: 10.1001/Archpsyc.1975.01760240118009  0.227
2004 Hollander E, Phillips A, King BH, Guthrie D, Aman MG, Law P, Owley T, Robinson R. Impact of recent findings on study design of future autism clinical trials. Cns Spectrums. 9: 49-56. PMID 14999175 DOI: 10.1017/S109285290000835X  0.226
2019 Garfunkel D, Anagnostou EA, Aman MG, Handen BL, Sanders KB, Macklin EA, Chan J, Veenstra-VanderWeele J. Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 31188026 DOI: 10.1089/Cap.2018.0171  0.225
2004 Lindsay RL, Leone S, Aman MG. Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders. Clinical Pediatrics. 43: 437-44. PMID 15208748 DOI: 10.1177/000992280404300504  0.225
1982 Aman MG, Werry JS. Methylphenidate and Diazepam in Severe Reading Retardation Journal of the American Academy of Child Psychiatry. 21: 31-37. PMID 7047619 DOI: 10.1097/00004583-198201000-00007  0.225
1980 Werry JS, Aman MG, Diamond E. Imipramine and methylphenidate in hyperactive children Journal of Child Psychology and Psychiatry and Allied Disciplines. 21: 27-35. PMID 7358801 DOI: 10.1111/J.1469-7610.1980.Tb00013.X  0.222
2008 Scahill L, Aman MG, McCracken JT, McDougle CJ, Vitiello B. Beware of over-interpreting negative trials. Journal of Autism and Developmental Disorders. 38: 1609-10. PMID 18594960 DOI: 10.1007/S10803-008-0581-7  0.221
2005 Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M, Arnold LE. Research knowledge among parents of children participating in a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 145-9. PMID 15689727 DOI: 10.1097/00004583-200502000-00006  0.22
2011 Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li X, Butter EM, Aman MG. The treatment of severe child aggression (TOSCA) study: Design challenges. Child and Adolescent Psychiatry and Mental Health. 5: 36. PMID 22074813 DOI: 10.1186/1753-2000-5-36  0.214
1991 Aman MG. Review and evaluation of instruments for assessing emotional and behavioural disorders Australia and New Zealand Journal of Developmental Disabilities. 17: 127-145. DOI: 10.1080/07263869100034351  0.212
1981 Singh NN, Aman MG. Effects of thioridazine dosage on the behavior of severely mentally retarded persons American Journal of Mental Deficiency. 85: 580-587. PMID 7023237  0.208
2004 Brown EC, Aman MG, Lecavalier L. Empirical classification of behavioral and psychiatric problems in children and adolescents with mental retardation. American Journal of Mental Retardation : Ajmr. 109: 445-55. PMID 15471511 DOI: 10.1352/0895-8017(2004)109<445:Ecobap>2.0.Co;2  0.205
2006 McDOUGLE CJ, Scahill L, Aman MG, Arnold LE, McCRACKEN JT, Tierney E, Vitiello B. Dr. McDougle and Colleagues Reply American Journal of Psychiatry. 163: 551-552. DOI: 10.1176/Appi.Ajp.163.3.551-A  0.202
1995 Aman MG, Sarphare G, Burrow WH. Psychotropic drugs in group homes: Prevalence and relation to demographic/psychiatric variables American Journal On Mental Retardation. 99: 500-509. PMID 7779345  0.201
1992 Aman MG, Werry JS, Turbott SH. Behavior of children with seizures. Comparison with norms and effect of seizure type. Journal of Nervous and Mental Disease. 180: 124-129. PMID 1737974 DOI: 10.1097/00005053-199202000-00010  0.2
1993 Aman MG. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities Annals of Clinical Psychiatry. 5: 171-188. PMID 7904217 DOI: 10.3109/10401239309148981  0.199
2017 Barterian JA, Arnold LE, Brown NV, Farmer CA, Williams C, Findling RL, Kolko DJ, Bukstein OG, Molina BSG, Townsend L, Aman MG. Clinical Implications From the Treatment of Severe Childhood Aggression (TOSCA) Study: A Re-Analysis and Integration of Findings. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 1026-1033. PMID 29173736 DOI: 10.1016/j.jaac.2017.09.426  0.195
1991 Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance. Journal of the American Academy of Child and Adolescent Psychiatry. 30: 816-824. DOI: 10.1016/S0890-8567(10)80022-X  0.194
1988 Aman MG, White AJ. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents Journal of Autism and Developmental Disorders. 18: 355-366. PMID 3170454 DOI: 10.1007/Bf02212192  0.182
1994 Aman MG, Werry JS, Paxton JW, Turbott SH. Effects of phenytoin on cognitive-motor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia. 35: 172-80. PMID 8112242 DOI: 10.1111/j.1528-1157.1994.tb02929.x  0.175
1987 Aman MG, Singh NN, White AJ. Caregiver perceptions of psychotropic medication in residential facilities Research in Developmental Disabilities. 8: 449-465. PMID 3671821 DOI: 10.1016/0891-4222(87)90025-4  0.174
1995 Aman MG, Bourgondien MEV, Wolford PL, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry. 34: 1672-1681. PMID 8543539 DOI: 10.1097/00004583-199512000-00018  0.174
2008 Field CJ, Aman MG, White AJ, Vaithianathan C. A single-subject study of imipramine in a mentally retarded woman with depressive symptoms. Journal of Intellectual Disability Research. 30: 191-198. PMID 3735414 DOI: 10.1111/J.1365-2788.1986.Tb01312.X  0.172
2011 Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, et al. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. Journal of Child and Adolescent Psychopharmacology. 21: 555-64. PMID 22070180 DOI: 10.1089/Cap.2010.0134  0.17
2020 Aman MG, Norris M, Kaat AJ, Andrews H, Choo TH, Chen C, Wheeler A, Bann C, Erickson C. Factor Structure of the Aberrant Behavior Checklist in Individuals with Fragile X Syndrome: Clarifications and Future Guidance. Journal of Child and Adolescent Psychopharmacology. PMID 32746626 DOI: 10.1089/Cap.2019.0177  0.17
2020 Aman MG, Pearson DA. Challenges for Child and Adolescent Psychiatric Research in the Era of COVID-19. Journal of Child and Adolescent Psychopharmacology. PMID 32515992 DOI: 10.1089/Cap.2020.0081  0.169
1986 Aman MG, Turbott SH. Incidental learning, distraction, and sustained attention in hyperactive and control subjects Journal of Abnormal Child Psychology. 14: 441-455. PMID 3760349 DOI: 10.1007/Bf00915437  0.168
1988 Aman M. Letters to the editor Journal of the American Academy of Child and Adolescent Psychiatry. 27: 821-822. PMID 3198577 DOI: 10.1097/00004583-198811000-00037  0.164
2003 Hanley B, Tassé MJ, Aman MG, Pace P. Psychometric Properties and Norms of the Family Needs Scale. Journal of Child and Family Studies. 12: 41-48. DOI: 10.1023/A:1021354008653  0.162
1980 Aman MG. Psychotropic drugs and learning problems - a selective review Journal of Learning Disabilities. 13: 87-97. PMID 7391681 DOI: 10.1177/002221948001300208  0.16
1985 Aman MG, Singh NN. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment Journal of Mental Deficiency Research. 29: 187-195. PMID 2863380 DOI: 10.1111/J.1365-2788.1985.Tb00327.X  0.16
1995 Aman MG, Burrow WH, Wolford PL. The aberrant behavior checklist-community: Factor validity and effect of subject variables for adults in group homes American Journal On Mental Retardation. 100: 283-292. PMID 8554775  0.158
2018 Aman MG, Arnold LE, Barterian JA. Clinical Relevance Versus Statistical Significance: Aman and Colleagues Respond to Editorial. Journal of the American Academy of Child and Adolescent Psychiatry. 57: 352-353. PMID 29706166 DOI: 10.1016/j.jaac.2017.12.012  0.157
1988 Watson JE, Aman MG, Singh NN. The psychopathology instrument for mentally retarded adults: psychometric characteristics, factor structure, and relationship to subject characteristics. Research in Developmental Disabilities. 9: 277-290. PMID 3175094 DOI: 10.1016/0891-4222(88)90005-4  0.156
1982 Aman MG, Singh NN. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior Applied Research in Mental Retardation. 3: 345-358. PMID 7168571 DOI: 10.1016/S0270-3092(82)80002-7  0.155
1981 Singh NN, Aman MG. Mental retardation: State of the field in New Zealand Applied Research in Mental Retardation. 2: 115-127. PMID 7052751 DOI: 10.1016/0270-3092(81)90046-1  0.152
1980 Aman MG, Mayhew JM. Consistency of cognitive and motor performance measures over two years in reading retarded children. Perceptual and Motor Skills. 50: 1059-65. PMID 7413379 DOI: 10.2466/Pms.1980.50.3C.1059  0.152
1997 Reiss S, Aman MG. The international consensus process on psychopharmacology and intellectual disability. Journal of Intellectual Disability Research : Jidr. 41: 448-55. PMID 9430048 DOI: 10.1111/J.1365-2788.1997.Tb00736.X  0.152
1997 Reiss S, Aman MG. The international consensus process on psychopharmacology and intellectual disability Journal of Intellectual Disability Research. 41: 448-455.  0.152
1975 Aman MG, Werry JS. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action Psychopharmacologia. 43: 163-168. PMID 1103207 DOI: 10.1007/Bf00421019  0.145
1986 Aman MG, Singh NN. A critical appraisal of recent drug research in mental retardation: The Coldwater studies Journal of Mental Deficiency Research. 30: 203-216. PMID 2878082 DOI: 10.1111/J.1365-2788.1986.Tb01315.X  0.144
1985 Aman MG. Drugs in mental retardation: Treatment or tragedy? Australia and New Zealand Journal of Developmental Disabilities. 11: 215-226. DOI: 10.3109/13668258508998641  0.144
1980 Hillas J, Somerfield S, Wilson J, Aman M. Azatadine maleate in perennial allergic rhinitis: effects on clinical symptoms and choice reaction time British Journal of Clinical Pharmacology. 10: 573-577. PMID 7008821 DOI: 10.1111/j.1365-2125.1980.tb00513.x  0.139
1985 White TJR, Aman MG. Pimozide treatment in disruptive severely retarded patients Australasian Psychiatry. 19: 92-94. DOI: 10.3109/00048678509158820  0.136
2015 Pouget JG, Gonçalves VF, Nurmi EL, P Laughlin C, Mallya KS, McCracken JT, Aman MG, McDougle CJ, Scahill L, Misener VL, Tiwari AK, Zai CC, Brandl EJ, Felsky D, Leung AQ, et al. Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes. Pharmacogenomics. 16: 5-22. PMID 25560467 DOI: 10.2217/Pgs.14.158  0.134
2007 Aman MG, Benson BA, Farmer CA, Hall KL, Malone KM. Project MED: effects of a Medication EDucation booklet series for individuals with intellectual disabilities. Intellectual and Developmental Disabilities. 45: 33-45. PMID 17428125 DOI: 10.1352/1934-9556(2007)45[33:Pmeoam]2.0.Co;2  0.133
1984 Aman MG, White AJ, Field C. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients - a pilot study Journal of Mental Deficiency Research. 28: 253-260. PMID 6396416 DOI: 10.1111/J.1365-2788.1984.Tb01018.X  0.132
1990 Aman MG, Kern RA. The Efficacy of Folic Acid in Fragile X Syndrome and Other Developmental Disabilities Journal of Child and Adolescent Psychopharmacology. 1: 285-295. DOI: 10.1089/Cap.1990.1.285  0.128
1985 Aman MG, Field CJ, Bridgman GD. City-wide survey of drug patterns among non-institutionalized mentally retarded persons Applied Research in Mental Retardation. 6: 159-171. PMID 4015083 DOI: 10.1016/S0270-3092(85)80068-0  0.127
2024 Halvorsen MB, Kildahl AN, Kaiser S, Axelsdottir B, Aman MG, Helverschou SB. Applicability and Psychometric Properties of General Mental Health Assessment Tools in Autistic People: A Systematic Review. Journal of Autism and Developmental Disorders. PMID 38613595 DOI: 10.1007/s10803-024-06324-3  0.12
2012 Sherwin CM, Saldaña SN, Bies RR, Aman MG, Vinks AA. Population pharmacokinetic modeling of risperidone and 9-hydroxyrisperidone to estimate CYP2D6 subpopulations in children and adolescents. Therapeutic Drug Monitoring. 34: 535-44. PMID 22929407 DOI: 10.1097/Ftd.0B013E318261C240  0.12
2017 Laxman DJ, Greenberg JS, DaWalt LS, Hong J, Aman MG, Mailick M. Medication use by adolescents and adults with fragile X syndrome. Journal of Intellectual Disability Research : Jidr. PMID 29034517 DOI: 10.1111/Jir.12433  0.108
1985 Aman M. Contraception in adolescence: knowing is not enough Soins. Gynecologie, Obstetrique, Puericulture, Pediatrie. 11-14. PMID 3853915  0.107
1998 Hanley B, Tassé MJ, Aman MG, Pace P. Psychometric Properties of the Family Support Scale with Head Start Families Journal of Child and Family Studies. 7: 69-77. DOI: 10.1023/A:1022912130180  0.106
2006 VINKS A, MANNAERT E, PAPPAS K, AMAN M. PIII-56Pharmacokinetics of risperidone and its 9-hydroxy-enantiomer metabolites in pediatric psychiatric patients Clinical Pharmacology & Therapeutics. 79: P73-P73. DOI: 10.1016/j.clpt.2005.12.264  0.104
2014 Aman M, Sitotaw M. Perception of summer cooperative graduates on employers generic skills preference, Haramaya University, Ethiopia International Journal of Instruction. 7: 181-190.  0.103
2007 Aman MG, Vinks AA, Remmerie B, Mannaert E, Ramadan Y, Masty J, Lindsay RL, Malone K. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders. Clinical Therapeutics. 29: 1476-86. PMID 17825699 DOI: 10.1016/J.Clinthera.2007.07.026  0.096
1990 Aman MG. Considerations in the use of psychotropic drugs in elderly mentally retarded persons Journal of Mental Deficiency Research. 34. PMID 2182880 DOI: 10.1111/J.1365-2788.1990.Tb01510.X  0.093
1990 Aman MG, Werry JS, Paxton JW, Turbott SH, Stewart AW. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia. 31: 51-60. PMID 2303013 DOI: 10.1111/J.1528-1157.1990.Tb05360.X  0.087
1991 Aman MG. Pharmacotherapy in the developmental disabilites: New developments Australia and New Zealand Journal of Developmental Disabilities. 17: 183-199. DOI: 10.1080/07263869100034401  0.084
2010 Barghchi M, Omar D, Aman MS. Sports facilities in urban areas: Trends and development considerations Pertanika Journal of Social Science and Humanities. 18: 427-435.  0.083
1981 Aman MG, Wakeman P. A simple system for control of the continuous performance test in psychopharmacological research Progress in Neuro-Psychopharmacology. 4: 621-626. PMID 7220677 DOI: 10.1016/0364-7722(81)90104-1  0.082
1997 Aman MG. Recent Studies in Psychopharmacology in Mental Retardation International Review of Research in Mental Retardation. 21: 113-146. DOI: 10.1016/S0074-7750(08)60278-5  0.081
2011 Aman M, Mahfooz S, Ur Rehman W. Handoff delay in cognitive radios - A concept paper on utilization of guard channels Proceedings - International Conference On Computer Networks and Information Technology. 211-215. DOI: 10.1109/ICCNIT.2011.6020931  0.079
1984 Aman MG. Mechanism for testing operant conditioning and body rocking in developmental disabilities Perceptual and Motor Skills. 58: 751-756. PMID 6206470 DOI: 10.2466/Pms.1984.58.3.751  0.078
1987 Aman MG, Werry JS, Paxton JW, Turbott SH. Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis. Epilepsia. 28: 115-124. PMID 3102218 DOI: 10.1111/J.1528-1157.1987.Tb03636.X  0.07
2006 Aman MG, Handen B. Reactions to "Ethical challenges and complexities of including people with intellectual disability as participants in research" by Dr Teresa Iacono Journal of Intellectual and Developmental Disability. 31: 180-182. DOI: 10.1080/13668250600876400  0.07
2016 Aman MJ, Kashanchi F. Zika Virus: A New Animal Model for an Arbovirus. Plos Neglected Tropical Diseases. 10: e0004702. PMID 27149628 DOI: 10.1371/Journal.Pntd.0004702  0.069
1987 Aman MG, Singh NN, Fitzpatrick J. The relationship between nurse characteristics and perceptions of psychotropic medications in residential facilities for the retarded Journal of Autism and Developmental Disorders. 17: 511-523. PMID 3680153 DOI: 10.1007/Bf01486967  0.068
1985 Aman M. City-wide survey of drug patterns among non-institutionalised retarded persons New Zealand Medical Journal. 98: 509. PMID 3859783  0.068
2011 Barghchi M, Omar DB, Aman MS, Kazemian S. The intangible impacts of sports facilities development: Case study of the Bukit Jalil national sports complex in Malaysia Isec 2011 - 6th International Structural Engineering and Construction Conference: Modern Methods and Advances in Structural Engineering and Construction. 253-258. DOI: 10.3850/978-981-08-7920-4-S1-F04-cd  0.065
2012 Jamshidi A, Hamzah MO, Aman MY. Effects of Sasobit® content on the rheological characteristics of unaged and aged asphalt binders at high and intermediate temperatures Materials Research. 15: 628-638. DOI: 10.1590/S1516-14392012005000083  0.065
1991 Aman MG, Kern RA, Arnold LE, McGhee DE. Fenfluramine and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry. 30: 507-508. PMID 2055893 DOI: 10.1097/00004583-199105000-00027  0.062
2015 Aman MN, Bhatti AU. Comparison of regression models to predict potential yield of wheat from some measured soil properties Pakistan Journal of Agricultural Sciences. 52: 239-256.  0.061
2000 Shigematsu T, Kubota E, Aman M. Adult respiratory distress syndrome as a manifestation of ovarian hyperstimulation syndrome. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 69: 169-70. PMID 10802090 DOI: 10.1016/S0020-7292(99)00202-7  0.061
1990 Glasspoole LA, Aman MG. Knowledge, attitudes, and happiness of nurses working with gerontological patients Journal of Gerontological Nursing. 16: 11-14. PMID 2303670 DOI: 10.3928/0098-9134-19900201-05  0.06
2003 Onoyama I, Fukushima K, Aman M, Satoh S, Nakano H. Can we predict the premature labor in patients with placenta previa?; a retrospective study on maternal symptoms during pregnancy Fukuoka Igaku Zasshi = Hukuoka Acta Medica. 94: 209-216. PMID 12934576  0.059
1983 Paxton JW, Aman MG, Werry JS. Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children. Epilepsia. 24: 716-724. PMID 6641647 DOI: 10.1111/J.1528-1157.1983.Tb04634.X  0.058
1997 Ziena HMS, Youssef MM, Aman ME. Quality attributes of black olives as affected by different darkening methods Food Chemistry. 60: 501-508. DOI: 10.1016/S0308-8146(96)00354-8  0.058
1984 Aman MM. Use of arabic in computerized information interchange Journal of the American Society For Information Science. 35: 204-210. DOI: 10.1002/asi.4630350403  0.056
2014 Aman MY, Shahadan Z, Noh MZM. A comparative study of anti-stripping additives in porous asphalt mixtures Jurnal Teknologi. 70: 139-145. DOI: 10.11113/jt.v70.3594  0.055
1989 Aman MM. Document delivery and interlibrary lending in the arab countries Interlending &Amp; Document Supply. 17: 84-88. DOI: 10.1108/EUM0000000003461  0.054
2004 Flarakos J, Luo W, Aman M, Svinarov D, Gerber N, Vouros P. Quantification of risperidone and 9-hydroxyrisperidone in plasma and saliva from adult and pediatric patients by liquid chromatography-mass spectrometry Journal of Chromatography A. 1026: 175-183. PMID 14763744 DOI: 10.1016/J.Chroma.2003.10.138  0.054
2014 Lim PH, Aman MS. The origins and development of athletics among the military, European and migrant communities in nineteenth-century Singapore, 1819-1899 International Journal of the History of Sport. 31: 644-665. DOI: 10.1080/09523367.2013.869212  0.053
2013 Tayyebi J, Aman M. On inverse linear programming problems under the bottleneck-type weighted Hamming distance Discrete Applied Mathematics. DOI: 10.1016/j.dam.2015.12.017  0.052
2016 Aman MJ. Chasing Ebola through the endosomal labyrinth Mbio. 7. DOI: 10.1128/mBio.00346-16  0.052
2016 Lim PH, Aman MS. The history of the South East Asian Peninsular Games, 1959-1975 International Journal of the History of Sport. 33: 545-568. DOI: 10.1080/09523367.2015.1062371  0.052
2013 Balis A, Aman M. The race race: assimilation in America Teaching in Higher Education. 18: 587-595. DOI: 10.1080/13562517.2013.774351  0.051
2015 Lim PH, Aman MS. The sporting lives of Sir Shenton Thomas and the male european internees at changi prison camp during the japanese occupation of Singapore, 1942-1945 International Journal of the History of Sport. 32: 466-483. DOI: 10.1080/09523367.2014.994203  0.05
2014 Tayyebi J, Aman M. Note on "inverse minimum cost flow problems under the weighted Hamming distance", European Journal of Operational Research. 234: 916-920. DOI: 10.1016/j.ejor.2013.11.014  0.049
2015 Ilyas A, Aman M, Saeed N. Delay Analysis of an Improved Wimax Macro-Femto Handover Technique and Cell Selection Algorithm Wireless Personal Communications. 85: 2157-2168. DOI: 10.1007/s11277-015-2897-x  0.043
2011 Hamzah MO, Aman MY, Shahadan Z. Resistance to disintegration of warm porous asphalt incorporating Sasobit® Australian Journal of Basic and Applied Sciences. 5: 113-121.  0.042
2015 Aman MY, Shahadan Z, Tamin NRM. A comparative study on properties of malaysian porous asphalt mixes with different bitumen contents Research Journal of Applied Sciences, Engineering and Technology. 9: 797-806.  0.042
2005 Aman M, Hirano K, Nishimura J, Nakano H, Kanaide H. Enhancement of trypsin-induced contraction by in vivo treatment with 17beta-estradiol and progesterone in rat myometrium. British Journal of Pharmacology. 146: 425-34. PMID 16056237 DOI: 10.1038/sj.bjp.0706345  0.039
2014 Aman MJ, Adhikari RP. Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy. Toxins. 6: 950-72. PMID 24599233 DOI: 10.3390/toxins6030950  0.038
1974 Aman MG, Sprague RL. The State-Dependent Effects of Methylphenidate and Dextroamphetamine Journal of Nervous and Mental Disease. 158: 268-279. PMID 4819605 DOI: 10.1097/00005053-197404000-00005  0.038
2016 Aman M, Nenovsky N, Mahamoud I. The informal system of remittances and currency board: Complementarity or antagonism? The case of Hawala transfers in Djibouti Savings and Development. 38: 133-154.  0.036
2002 Bourisli RI, Chehadeh D, Aman M, Hussain H. The integration of an industrial DCS with pilot plants Hydrocarbon Asia. 12: 64-67.  0.035
2001 Aman MJ, Tosello-Trampont AC, Ravichandran K. FcγRIIB1/SHIP-mediated Inhibitory Signaling in B Cells Involves Lipid Rafts Journal of Biological Chemistry. 276: 46371-46378. DOI: 10.1074/Jbc.M104069200  0.035
2009 Aman M, Sikdar B, Parekh S. Scalable peer-to-peer video streaming in WiMAX networks Globecom - Ieee Global Telecommunications Conference. DOI: 10.1109/GLOCOM.2009.5425631  0.035
2006 Struss D, Aman M, Ahmad R, Southwick SM. Identifying cultivars and genetic diversity of apricot by molecular markers Acta Horticulturae. 701: 253-256.  0.033
2014 Sinha AC, Singh PM, Grewal N, Aman M, Dubowitz G. Comparison between continuous non-invasive estimated cardiac output by pulse wave transit time and thermodilution method Annals of Cardiac Anaesthesia. 17: 273-277. PMID 25281622 DOI: 10.4103/0971-9784.142059  0.033
2011 Warfield KL, Aman MJ. Advances in virus-like particle vaccines for filoviruses Journal of Infectious Diseases. 204. PMID 21987741 DOI: 10.1093/infdis/jir346  0.032
1987 Aman MG. Overview of pharmacotherapy: Current status and future directions Journal of Mental Deficiency Research. 31: 121-130. PMID 2887660 DOI: 10.1111/J.1365-2788.1987.Tb01349.X  0.032
2015 Aman M. Agribusiness and value chain management students' attitude towards entrepreneurship in Haramaya University, Ethiopia: Promises or practices of modularisation? International Journal of Management and Enterprise Development. 14: 1-10. DOI: 10.1504/IJMED.2015.069306  0.032
2012 Aman MN, Sikdar B. A CART based mechanism for collision detection in IEEE 802.11 2012 Ieee Latin-America Conference On Communications, Latincom 2012 - Conference Proceedings. DOI: 10.1109/Tla.2013.6568834  0.031
1990 Aman MM, Fong WW, Diodato V. Selecting a local area network for an academic environment The Electronic Library. 8: 249-253. DOI: 10.1108/eb044991  0.03
2012 Aman MN, Chan WK, Sikdar B. Collision detection in IEEE 802.11 networks by error vector magnitude analysis Globecom - Ieee Global Telecommunications Conference. 5218-5223. DOI: 10.1109/GLOCOM.2012.6503949  0.03
2014 Aman MN, Sikdar B. A wireless MAC protocol with efficient packet recovery 2014 Ieee 20th International Workshop On Local and Metropolitan Area Networks, Lanman 2014. DOI: 10.1109/LANMAN.2014.7028623  0.03
1969 Aman MM. Pratt institute center for international librarianship studies: A review of functions, services and collections International Library Review. 1: 479-486. DOI: 10.1016/S0020-7837(69)80030-0  0.03
2014 Aman MN, Sikdar B, Chan WK. Efficient packet recovery in wireless networks Ieee Wireless Communications and Networking Conference, Wcnc. 1791-1796. DOI: 10.1109/WCNC.2014.6952521  0.03
1983 Aman MB, Moustafa EK, Zoueil ME, Ghaly MH. Effect of frozen storage on the chemical and technological characteristics of Egyptian crab meat Zeitschrift FüR Lebensmittel-Untersuchung Und -Forschung. 177: 97-100. DOI: 10.1007/BF01043072  0.029
2003 Zardi Z, Rahman AA, Aman MI. Air pollution modeling surrounding Serdang Power Station Advances in Air Pollution. 13: 143-151.  0.028
2016 Sun Y, Aman M, Espinoza DN. Assessment of mechanical rock alteration caused by CO2-water mixtures using indentation and scratch experiments International Journal of Greenhouse Gas Control. 45: 9-17. DOI: 10.1016/j.ijggc.2015.11.021  0.028
1977 Aman ME, Efimov AD. Effect of prolonged cold storage and subsequent heat treatment on the fractional composition of fish muscle proteins Voprosy Pitaniia. 73-79. PMID 883223  0.028
2012 Aman MN, Sikdar B. Distinguishing between channel errors and collisions in IEEE 802.11 2012 46th Annual Conference On Information Sciences and Systems, Ciss 2012. DOI: 10.1109/CISS.2012.6310924  0.028
1972 Aman MM. The year's work in international librarianship: 1970 International Library Review. 4: 235-250. DOI: 10.1016/0020-7837(72)90034-9  0.027
1983 Aman MB. Effect of cooking and preservation methods on the Water Holding Capacity (WHC) of mullet fish in relation with changes occurred in muscle proteins Zeitschrift FüR Lebensmittel-Untersuchung Und -Forschung. 177: 345-347. DOI: 10.1007/BF01042194  0.026
1978 Werry JS, Aman MG. Dietary control of hyperkinesis New Zealand Medical Journal. 88: 297-298. PMID 281634  0.025
2000 Aman MJ, Ravichandran KS. A requirement for lipid rafts in B cell receptor induced Ca2+ flux Current Biology. 10: 393-396. PMID 10753749 DOI: 10.1016/S0960-9822(00)00415-2  0.024
2014 Rahmah A, Blogg J, Silitonga N, Aman M, Michael Power R. The health of female prisoners in Indonesia. International Journal of Prisoner Health. 10: 252-61. PMID 25764293 DOI: 10.1108/IJPH-08-2013-0038  0.024
2016 Aman M, Rai V R. Antifungal activity of novel indole derivative from endophytic bacteria Pantoea ananatis 4G-9 against Mycosphaerella musicola Biocontrol Science and Technology. 26: 476-491. DOI: 10.1080/09583157.2015.1126223  0.023
2014 Aman M. Diagonal and monomial solutions of the matrix equation AXB = C Iranian Journal of Mathematical Sciences and Informatics. 9: 30-41.  0.023
1997 Aman MJ, Leonard WJ. Cytokine signaling: Cytokine-inducible signaling inhibitors Current Biology. 7. PMID 9382832  0.022
2016 Aman M, Khan A, Abdullah A, Ullah I. Position-based Unicast routing protocols for mobile Ad Hoc networks using the concept of blacklisting Lecture Notes in Electrical Engineering. 348: 1195-1206. DOI: 10.1007/978-81-322-2580-5_109  0.022
1994 Burch PT, Aman M, Burch JW. Modification of glutathione content in platelet concentrates by the use of acivicin Transfusion. 34: 421-426. PMID 7910710  0.02
2007 Aman MC. Long wavelength VCSELs for sensing applications 2007 International Nano-Optelectronics Workshop, Inow. 75-76. DOI: 10.1109/INOW.2007.4302886  0.02
1989 Aman MM, Sweetland JH. Multidisciplinary Ph.D. program at the University of Wisconsin-Milwaukee Proceedings of the Hawaii International Conference On System Science. 4: 279-286.  0.02
1996 Schmale MC, Aman MR, Gill KA. A retrovirus isolated from cell lines derived from neurofibromas in bicolor damselfish (Pomacentrus partitus) Journal of General Virology. 77: 1181-1187. PMID 8683205  0.019
1973 Aman MM. A world of communication: A 1972 theme for the ASIS annual conference International Library Review. 5: 195-198.  0.019
1994 Peschel C, Aman MJ, Huber C. Interferon-α as an antagonist to proinflammatory and hematopoietic cytokines Journal of Interferon Research. 14: 289-290. PMID 7861033  0.018
1987 Aman MA, Aman MJ. Reference services and global awareness Reference Librarian. 7: 45-50. DOI: 10.1300/J120v07n17_04  0.018
2010 Aman M, Hirano M, Kanaide H, Hirano K. Upregulation of proteinase-activated receptor-2 and increased response to trypsin in endothelial cells after exposure to oxidative stress in rat aortas. Journal of Vascular Research. 47: 494-506. PMID 20431298 DOI: 10.1159/000313877  0.017
2012 Khalid MU, Gul M, Aman MM, Hashmi A. Energy conservation through lighting audit Pecon 2012 - 2012 Ieee International Conference On Power and Energy. 840-845. DOI: 10.1109/PECon.2012.6450335  0.015
1992 Aman MM. Libraries and information systems in the Arab Gulf States: After the war Journal of Information Science. 18: 447-451. DOI: 10.1177/016555159201800605  0.015
1973 Aman ME. Effect of different methods of heat processing on the amino acid makeup of the proteins of the mirror carp Voprosy Pitaniia. 32: 69-72. PMID 4780619  0.014
1975 Verel D, Ward C, Aman M. Comparison of Triosil 370 with Urografin 76 and Hypaque 65 for coronary arteriography Heart. 37: 1049-1052. PMID 1191419 DOI: 10.1136/hrt.37.10.1049  0.014
2015 Aman M, Rai VR. Potent toxigenic effect of Mycosphaerella musicola on locally growing banana varieties Phytoparasitica. 43: 295-301. DOI: 10.1007/s12600-015-0456-3  0.013
1993 Aman MM. Education for library and information science in the Soviet Autonomous Republics Journal of Information Science. 19: 155-160. DOI: 10.1177/016555159301900208  0.012
1988 Glasspoole LA, Aman MG. Atttitudes and knowledge of gerontological nurses toward psychotropic drugs Gerontologist. 28: 667-671. PMID 3229652 DOI: 10.1093/Geront/28.5.667  0.012
2016 Warfield KL, Aman MJ. Role of small biotechnology companies in the fledgling biodefense vaccine industry Expert Review of Vaccines. 15: 1079-1082. DOI: 10.1586/14760584.2016.1168702  0.012
1980 Aman MM. The white house conference on library and information services, Washington, D.C. November 15-19, 1979 International Library Review. 12: 325-342. DOI: 10.1016/0020-7837(80)90040-0  0.011
2015 Aman MS. Sport policy and Islam in Malaysia Sport in Islam and in Muslim Communities. 191-204. DOI: 10.4324/9781315745480  0.01
2015 Fruehauf N, Herrmann M, Baur H, Aman M. Low temperature processes for metal-oxide thin film transistors Proceedings of Am-Fpd 2015 - 22nd International Workshop On Active-Matrix Flatpanel Displays and Devices: Tft Technologies and Fpd Materials. 39-42. DOI: 10.1109/AM-FPD.2015.7173191  0.01
2006 Aman MG. Dr. Aman replies [4] Journal of Clinical Psychiatry. 67: 2031-2032.  0.01
1978 Jawad F, Aman M. Diabetes mellitus--an analysis of 1192 patients Journal of the Pakistan Medical Association. 28: 44-46. PMID 100627  0.01
1972 Aman ME, Smirnova GA. Effect of heat on the composition of phospholipids of fish muscle Voprosy Pitaniia. 31: 90-92. PMID 5042225  0.01
1970 Aman MM. Egyptian university libraries International Library Review. 2: 175-181. DOI: 10.1016/0020-7837(70)90058-0  0.01
1970 Aman MM. The year’s work in international librarianship: 1969 International Library Review. 2: 401-413. DOI: 10.1016/0020-7837(70)90013-0  0.01
Hide low-probability matches.